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Abstract
Background: Antibiotics are the widely prescribed drugs for children and most likely to be related with adverse
reactions. Record on adverse reactions and allergies from antibiotics considerably affect the prescription choices.
We consider this a biomedical decision-making problem and explore hidden knowledge in survey results on data
extracted from a big data pool of health records of children, from the Health Center of Osijek, Eastern Croatia.
Results: We applied and evaluated a k-means algorithm to the dataset to generate some clusters which have
similar features. Our results highlight that some type of antibiotics form different clusters, which insight is most
helpful for the clinician to support better decision-making.
Conclusions: Medical professionals can investigate the clusters which our study revealed, thus gaining useful
knowledge and insight into this data for their clinical studies.
Background
Antibiotics are the drugs most widely prescribed to chil-
dren and are most likely to be associated with allergic and
adverse reactions [1-4]. A reaction to a drug is known as
an allergic reaction if it involves an immunologic reaction
to a drug. It may happen in the form of immediate or
non-immediate (delayed) hypersensitivity reactions.
Immediate reactions are usually mediated with IgE antibo-
dies (often elevated in persons with inherited susceptibility
to allergic diseases, called atopy), whereas non-immediate
reactions can be mediated with several other immune
mechanisms [5]. The clinical manifestations of antibiotic
allergy include skin reactions (varying from local and mild
general to severe general reactions), organ-specific reac-
tions (most commonly occurring in the form of blood dys-
crasias, hepatitis and interstitial nephritis) and systemic
reactions (usually corresponding with anaphylaxis) [5].
Many reactions to drugs mimic symptoms and signs of
the allergic reactions, although being caused with non-
immunologic mechanisms. In many cases, also, pathologic
mechanisms remain completely unclear. This is the reason
why these reactions are often considered together and
commonly named adverse reactions and allergy (ARA) [6].
This term is especially appropriate for use in primary
health care setting, where patients who had experienced
ARA on antibiotics have rarely been referred to testing.
Moreover, diagnostic tests have some limitations and are
only standardized for penicillin allergy [6].
Antibiotic classes with higher historical use have been
shown to have higher allergy prevalence [7]. Published
papers on frequency, risk factors and preventability of
this medical problem in the general population, and espe-
cially in children, are scarce. Available data implicate
female sex, frequent use, older age, insufficient prescrib-
ing strategy and monitoring of prescribed medications, as
the primary factors accounting for higher prevalence of
ARA on antibiotics among adults. Similar data for chil-
dren are completely absent [8].
The aim of this study is to explore hidden knowledge in
the survey data extracted from health records on adverse
reactions and allergy on antibiotics in children in the
town of Osijek, Eastern Croatia. We plan to obtain some
serious and useful information in electronic health
records that are not easily recognized by researchers,
clinicians and pharmaceutical companies.
Related work
There have been many works carried out for knowledge
discovery on diseases and drug adverse events associations.
Kadoyama et al. searched the FDA’s AERS (Adverse Event
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Reporting System) and performed a study to reveal
whether the database could offer the hypersensitivity reac-
tions caused by anticancer agents, paclitaxel, docetaxel,
procarbazine, asparaginase, teniposide and etoposide.
They used some data mining algorithms, such as “propor-
tional reporting ratio (PRR), the reporting odds ratio
(ROR) and the empirical Bayes geometric mean (EBGM)
to identify drug-associated adverse events and conse-
quently, they found some associations” [9].
Tsymbal et al. investigated antibiotics resistance data
and proposed a new ensemble machine learning techni-
que, “where a set of models are built over different time
periods and the best model is selected”[10]. They ana-
lyzed the data collected from the Burdenko Institute of
Neurosurgery in Russia and the dataset consisted of
some features such as: patient and hospitalization
related information, pathogen and pathogen groups and
antibiotics and antibiotic groups. Their experiments
with the data show “that dynamic integration of classi-
fiers built over small time intervals can be more effective
than” the best single learning algorithm applied “in
combination with feature selection”, which gives the
best known accuracy for the considered problem
domain [10].
Lamma et al. “described the application of data mining
techniques in order to automatically discover association
rules from microbiological data and obtain alarm rules
for data validation”[11]. Their dataset consists of “ infor-
mation about the patient such as sex, age, hospital unit,
the kind of material (specimen) to be analyzed (e.g.,
blood, urine, saliva, pus, etc.), bacterium and its antibio-
gram”[11]. They applied the Apriori algorithm to the
dataset and developed some interesting rules [11].
Harpaz et al. reported on an approach that automati-
cally searches whether a specific adverse event (AE) is
caused by a specific drug based on the content of
PubMed citations[12]. A drug-ADE classification
method was initially developed to detect neutropenia
based on a pre-selected set of drugs. This method was
then applied to a different set of 76 drugs to determine
if they caused neutropenia. For further proof of concept
they applied this method to 48 drugs to determine
whether they caused another AE, myocardial infarction.
These results showed that AUROC was 0.93 and 0.86
respectively [12].
Lin et al. offered an interactive system platform for the
detection of ADRs(Adverse Drug Reaction). By integrat-
ing an ADR data warehouse and innovative data mining
techniques, the proposed system not only provides OLAP
style multidimensional analysis of ADRs, but also allows
the interactive discovery of relations between drugs and
symptoms, known a drug-ADR association rule, which
can be further developed using other factors of interest
to the user, such as demographic information. The
experiments indicate that interesting and valuable drug-
ADR association rules can be efficiently mined [13].
Warrer et al. investigated studies that “use text-mining
techniques in narrative documents stored in electronic
patient records (EPRs) to investigate ADRs”[14]. They
searched PubMed, Embase, Web of Science and Interna-
tional Pharmaceutical Abstracts without restrictions
from origin until July 2011. They included empirically
based studies on “text mining of electronic patient
records (EPRs) that focused on detecting ADRs, exclud-
ing those that investigated adverse events not related to
medicine use”[14]. They extracted information on “study
populations, EPR data sources, frequencies and types of
the identified ADRs, medicines associated with ADRs,
text-mining algorithms used and their performance”[14].
“Seven studies, all from the United States, were eligible
for inclusion in the review. Studies were published from
2001, the majority between 2009 and 2010”[14]. “Text-
mining techniques varied over time from simple free
text searching of outpatient visit notes and inpatient dis-
charge summaries to more advanced techniques invol-
ving natural language processing (NLP) of inpatient
discharge summaries”[14]. “Performance appeared to
increase with the use of NLP, although many ADRs
were still missed”[14]. “Due to differences in study
design and populations, various types of ADRs were
identified and thus we could not make comparisons
across studies”[14]. “The review underscores the feasibil-
ity and potential of text mining to investigate narrative
documents in EPRs for ADRs”[14]. However, more
empirical studies are needed to evaluate whether text
mining of EPRs can be used systematically to collect
new information about ADRs [14].
Forster et al. identified studies evaluating electronic
ADE detection from the MEDLINE and EMBASE data-
bases[15]. They included “studies if they contained origi-
nal data and involved detection of electronic triggers
using information systems”[15]. “They abstracted data
regarding rule characteristics including type, accuracy,
and rational “[15]. Honigman et al. also developed a
program that combines four computer search methods,
including text searching of the electronic medical
record, to detect ADEs in outpatient settings[16].
Although further refinements to their methodology
should improve the overall accuracy of detection, their
data demonstrate that the methodology of combining
several searching tools can be successful in retrospec-
tively detecting with moderate sensitivity ADEs in the
electronic medical record [16].
The influence of resident gut microbes on xenobiotic
metabolism has been explored at different levels
throughout the past five decades[17]. “However, with
the advance in sequencing and pyrotagging technologies,
pointing out the influence of microbes on xenobiotics
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had to evolve from assessing direct metabolic effects on
toxins and botanicals by conventional culture-based tech-
niques to elucidating the role of community composition
on drugs metabolic profiles through DNA sequence-
based phylogeny and metagenomics”[17]. Following the
completion of the Human Genome Project, the rapid,
substantial growth of the Human Microbiome Project
(HMP) opens new horizons for studying how micro-
biome compositional and functional variations affect
drug action, fate, and toxicity (pharmacomicrobiomics),
notably in the human gut. The HMP continues to char-
acterize the microbial communities associated with the
human gut, determine whether there is a common gut
microbiome profile shared among healthy humans, and
investigate the effect of its alterations on health. Saad et
al. offered “a glimpse into the known effects of the gut
microbiota on xenobiotic metabolism, with emphasis on
cases where microbiome variations lead to different ther-
apeutic outcomes”[17]. They discussed a few examples
representing how the microbiome interacts with human
metabolic enzymes in the liver and intestine[17]. In addi-
tion, they attempted to envisage a roadmap for the future
implications of the HMP on therapeutics and persona-
lized medicine [17].
Some researchers also investigated gene-disease asso-
ciations. Arrais et al. presented a study on innovative
computational method that addresses the problem of
using disperse biomedical knowledge to select the best
candidate gene associated with a disease[18]. The
method that they offered uses a network representation
of current biomedical knowledge that includes biomedi-
cal concepts such as genes, diseases, pathways and bio-
logical process [18]. Furlong also reviewed recent
literature on network analysis related to disease [19].
Methods
The study population and data sources
The study was done on the population of 1491 children
(769 children of the school age, 7-18 years old, the rest
of the preschool age), all patients in the same Health
Center in the town of Osijek, Eastern Croatia, cared for
by a family physician and a primary pediatrician teams.
Data were extracted from the health records of these
children. Knowledge of risk factors for ARA on antibiotics
in children are scarce. In making a choice for data collec-
tion, a co-author physician used personal knowledge on
factors influencing the immunologic reactions together
with information from the studies on risk factors for aller-
gic diseases in children [20-27]. Data extraction, from the
patients health records, was guided by a multi-item chart,
in an advance prepared by this co-author. In addition, par-
ents of children recorded on ARA on antibiotics were
interviewed by telephone, on a family history of ARA on
antibiotics and other allergic and chronic diseases, in
which pathogenesis, in a great part, immunologic mechan-
isms are involved. Data were summarized.
Registered information on ARA on antibiotics was
found in health records of 46 children, out of a total of
1491 children screened, implicating the overall preva-
lence of ARA on antibiotics of 3,15%. However, higher
prevalence was found in children of the school age
(4,9%), then in those of the preschool age (1,1%), data
probably reflecting the cumulative incidence rates with
age. When the incidence data were however estimated,
it has been shown that ARA on antibiotics, in our study
population, can be expected to occur predominantly in
preschool age (33/46 cases, 71,1%).
Of registered ARA events, almost all were mild-moder-
ate skin reactions. Only one case was in need for hospita-
lization (a 18-year-old girl, treated with the combination
of amoxicillin and clavulonic acid). All data, including
descriptions of ARA events (upon which classification of
severity reaction was made) and diagnoses of diseases,
were based on the native physicians’ records.
Clustering analysis by k-means algorithm
Cluster analysis is one of the important data analysis
methods in data mining research. “The process of
grouping a set of physical or abstract objects into classes
of similar objects is called clustering. A cluster is a col-
lection of data objects that are similar to one another
and are dissimilar to the objects in other clusters” [28].
Cluster analysis has been widely used in numerous
applications, including pattern recognition, data analysis,
image processing and biomedical research.
There are some distance measures used in cluster ana-
lysis. The widely used distance measure is Euclidean dis-





Euclidean distance satisfy the following mathematic
requirements of a distance function:
1. d(x,y) ≥ 0: Distance is a nonnegative number
2. d(x,x) = 0: The distance of an object to itself is 0.
3. d(x,y) = d(y,x): Distance is a symmetric function.
4. d(x,y) ≤ d(x,h) + d(h,y): Going directly from object
× to object y in space is no more than making a
detour over any other object h(triangular inequality)
[28,29].
In this study, we use the k-means algorithm to survey
results on adverse reactions and allergy (ARA) on antibio-
tics in children. The k-means algorithm is a type of parti-
tioning algorithm and is simple and effective. The k-means
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algorithm is widely used due to easy implementation and
fast execution. “Let X = {xi}, i = 1,...,n be the set of
n d-dimensional points to be clustered into a set of K clus-
ters, C = {ck, k = 1,...,K}. K-means algorithm finds a parti-
tion such that the squared error between the empirical
mean of a cluster and the points in the cluster is mini-
mized. Let µk be the mean of cluster ck”[28,29]. The






The goal of k-means is to minimize the sum of the
squared error (SSE) over all k clusters. The formula of







“K-means starts with an initial partition with k clusters
and assign patterns to clusters so as to reduce the
squared error”[28,29]. Since the squared error always
decrease with an increase in the number of clusters k
(with SE = 0 when k = n), it can be minimized only for
a fixed number of clusters.
The pseudo code of a k-means algorithm is as follows:
1. arbitrarily choose k objects as the initial cluster
centers
2. repeat
3. (re)assign each object to the cluster to which the
object is the most similar, based on the mean value
of the objects in the cluster
4. update the cluster means, i.e., calculate the mean
value of the objects for each cluster
5. until no change [28], [29].
Results
We selected samples from the survey results and created
a dataset. Table 1 lists the antibiotics used in the dataset.
The dataset consists of 26 attributes and 42 instances
(Table 2, Table 3 and Table 4). The k-means algorithm
was used to explore some hidden clusters in the dataset.
WEKA 3.6.8 software was used. “WEKA is a collection of
machine learning algorithms for data mining tasks and is
an open source software”[30,31]. The software consists of
tools for data pre-processing, classification, regression,
clustering, association rules and visualization [30,31].
K-means algorithm needs the number of clusters (k) in
the data to be pre-specified. Finding the appropriate num-
ber of clusters for a given dataset is generally a trial and
error process made more difficult by the subjective nature
of deciding what ‘correct’ clustering[32]. The performance
of a clustering algorithm may be affected by the chosen
value of k. Reported studies on k-means clustering and its
applications usually do not contain any explanation or jus-
tification for selecting particular values for k [32].
“The k-means algorithm implementation in many data
analysis software packages requires the number of clus-
ters to be defined by the user”[32]. “To find a satisfac-
tory clustering result, usually, a number of iterations are
needed where the user executes the algorithm with dif-
ferent values of k “[32]. In order to evaluate the perfor-
mance of simple k-means algorithm in our study, two
test modes were used, training set and percentage split
(holdout method). The training set refers to a widely
used experimental testing procedure where the database
is randomly divided into k disjoint blocks of objects,
then the data mining algorithm is trained using k-1
blocks and the remaining block is used to test the per-
formance of the algorithm, this process is repeated k
Table 1 Type of antibiotics used in survey
Type of antibiotics
Short name used in the dataset Full name and information
ampicillin eritrom
cef& pen cefalosporins & penicillin
pen&klav penicillin & amoxicillin+clavulanic acid
klav amoxicillin+clavulanic acid - a broad-spectrum
azitrom azithromycin - a macrolide group
cef cefalosporins - a broad-spectrum
fenoksi fenoksimetil penicillin - per os penicillin, a narrow-spectrum
cefuroks cefuroxime - the second generation of cefalosporins
pen penicillin
sulfa sulfamethoxazole
eritrom erythromycin - a macrolide antibiotic of an older generation
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times[33]. At the end, the recorded measures are aver-
aged. It is common to choose k = 10 or any other size
depending mainly on the size of the original dataset[33].
In percentage split (holdout method), the database is
randomly split into two disjoint datasets[33]. The first
set, which the data mining system reveals knowledge
from the training set. The revealed knowledge may be
tested against the second set which is called test set, it
is common to randomly split a dataset under the mining
task into 2 parts and has 66% of the objects of the origi-
nal database as a training set and the rest of objects as a
test set[33]. Once the tests were carried out using our
dataset, results were collected and an overall comparison
was conducted [33].
We also tried different number of clusters (2<=k < = 5)
for each test mode and we observed the results of number
of iterations, sum of squared errors and runtime. Sum of
squared error (SSE) is an evaluation measure that deter-
mines how closely related are objects in a cluster[34].
The results after analysis are described in Table 5 and
6. We compared the results of the number of clusters
obtained by simple k-means algorithm and we found
that greater number of clusters produced smaller sum
of squared errors. For example, when k value is 2 which
is default in Weka, sum of squared error is 459.114, on
the other hand, when k value increased to 4, new value
of sum of squared error is 430.279 (Figure 1). Table 5
shows clusters with training set mode and with k = 4.
The results of the k-means algorithm revealed some
patterns in the survey data and four clusters were gener-
ated (Table 6). According to the results, some types of
antibiotics form their own clusters such as cef&pen,
pen, fenoksi and ampicilin. Medical researchers and
clinicians can consider and explore these patterns to
create some medical ideas.
Evaluation of clustering results
One of the main issues in cluster analysis is the evaluation
of clustering results to find the partitioning that best fits
the underlying data [35]. “There are three types of validity
methods:1) External validity indexes, 2) Internal validity
indexes, 3) Relative validity indexes” [36].
External cluster validity metrics use some predefined
knowledge, for example, class labels or number of clus-
ters for quality evaluation. In this case, good cluster
structure means the same as predefined class structure in
Table 2 The attributes used in the dataset (1-9)
No Attribute Description Type
1 Age The patient’s age Numeric
2 Age of ARA Age when the allergic/adverse reaction on antibiotics occurred Numeric
3 Type of antibiotic Generic name of the antibiotic by which the allergic reaction was provoked Nominal
4 Severity reaction The clinically graded allergic/adverse reaction Ordinal
5 Age of the 1st antibiotic use (y) Age when the first antibiotic was used Numeric
6 Other allergic disease (skin) Does a child have some other allergic disease? (manifestation on the skin) Nominal (Yes, No)
7 Other allergic disease (rhinitis) Does a child have some other allergic disease? (in the form of allergic rhinitis) Nominal (Yes, No)
8 Other allergic disease
(bronchitis)
Does a child have some other allergic disease? (in the form of obstructive bronchitis) Nominal (Yes, No)
9 Other allergic disease (asthma) Does a child have some other allergic disease? (in the form of asthma) Nominal
(Yes, No)
Table 3 The attributes used in the dataset (10-17).




11 Perinatal disorders Disorders occurring during delivery and the first hours after the birth Nominal
(Yes, No)
12 The child birth order Born as the first, or the second, etc., child in order Ordinal




14 Age of severe respiratory
disease
Age when some type of severe respiratory disease occurred Numeric
15 Otits media Otits media Nominal
(Yes, No)
16 Age of otitis media Age when otitis media occurred Numeric
17 Other infections Had there been some other infection before the allergic/adverse reaction on
antibiotics occured?
Nominal (Yes, No)
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the data set. Popular external indexes are Rand index,
Jaccard index and Fowlkes-Mallows index. Internal
approach evaluates clustering results in terms of quanti-
ties that involve the vectors of dataset themselves (e.g.
proximity matrix [36].
The main idea of relative approach is the evaluation of
cluster structure by comparing it with other cluster
structures, resulting by the same algorithms but with
different input parameters or by the different algorithms.
In this study, we used external cluster validity meth-
ods such as Rand Index, Jaccard Index and F-measure
and then compared k-means algorithm results with
other clustering algorithms.
Rand index
“This index measures the number of pair wise agree-
ments between the set of discovered clusters K and a
set of class labels C, is given by:
R =
a + d
a + b + c + d
Where a denotes the number of pairs of data points
with the same label in C and assigned to the same clus-
ter in K, b denotes the number of pairs with the same
label, but in different clusters, c denotes the number of
pairs in the same cluster, but with different class labels
and d denotes the number of pairs with a different label
in C that were assigned to a different cluster in
K“[37,38]. The index results in 0 ≤ R ≤ 1 , where a
value of 1 indicates that C and K are identical. A high
value for this index generally indicates a high level of
agreement between a clustering and the natural classes
[37,38].
Jaccard index
“Jaccard index, used to assess the similarity between dif-
ferent partitions of the same dataset, the level of agree-
ment between a set of class labels C and a clustering
result K is determined by the number of pairs of points
assigned to the same cluster in both partitions:
J =
a
a + b + c
Where a denotes the count of pairs of points with the
same label in C and assigned to the same cluster in K, b
denotes the count of pairs with the same label, but in
different clusters and c denotes the number of pairs in
the same cluster, but with different class labels”[37-39].
The index results in 0 ≤ J ≤ 1, where a value of 1 indi-
cates that C and K are identical [37-39].
Fowlkes-Mallows index
Let K the set of discovered clusters and C be the set of
class labels. Let A be the set of all the data point pairs
corresponding to the same class in C, and B the set of
Table 4 The attributes used in the dataset (17-26).
18 Other infections (the number
of episodes)
How many episodes of infections had there been before the allergic/adverse reaction on
antibiotics occurred?
Nominal
19 Varicella Did the varicella infection occur? Nominal
(Yes, No)
20 Age of varicella Age when varicella infection occurred Numeric
21 Hospitalization <2y of age Hospitalization in the very early childhood Nominal
(Yes, No)
22 Number of infections per
year
An average number of infections per year in a particular child, independently on when the
allergic/adverse reaction on antibiotics occurred
Numeric
23 Antibiotic exposure before
ARA
How many times antibiotics had been prescribed before the allergic/ adverse reaction on
antibiotics occurred?
Ordinal
24 Family history on ARA Family history on allergic/adverse reactions on antibiotics Nominal
(Positive,
Negative)
25 Allergic diseases in family Have there been other allergic diseases in family members? Nominal
(Yes, No)
26 Chr diseases in family Whether there have been other chronic diseases in family members? Nominal
(Yes, No)
Table 5 Evaluation of cluster analysis with percentage
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all the data point pairs corresponding to the same clus-
ter in K[37]. Then the probability that a pair of vertices
which are in the same class under C, are also in the




It is clear that this equation is asymmetric, i.e. P(C,K)
≠ P(K,C), Fowlkes-Mallows Index is defined as the geo-




The value of the Fowlkes-Mallows Index is between 0
and 1, and a high value means better accuracy [37].
K-medoids algorithm
k-medoids is a kind of k-means clustering approach and
conventional partitioning technique of clustering that
clusters the data set of m data points into k clusters. “It
attempts to minimize the squared error, which is the
distance between data points within a cluster and a
point designated as the center of that cluster”[37]. In
contrast to the k-means algorithm, k-medoids algorithm
selects data points as cluster centers(or medoids). A
medoid is a data point of a cluster, whose average dis-
similarity to all the other data points in the cluster is
minimal i.e. it is a most centrally located data point in
the cluster [37].
K-median clustering algorithm
K-median clustering algorithm is a type of k-means
clustering method like k-medoids algorithm and it cal-
culates the median for each cluster and determines its
centroid.
Single link clustering algorithm
Single link clustering algorithm performs single-link
(nearest-neighbour) cluster analysis on an arbitrary dis-
similarity coefficient and produces a representation of
the resultant dendrogram which can readily be con-
verted into the usual tree-diagram [40].
We conducted the performance evaluation of the fol-
lowing clustering techniques: k-means, k-medoids, k-
medians and single link clustering with external cluster
validity metrics (Table 7). According to Table 7, k-med-
ians algorithm provides maximum values for all of the
external validity metrics and hence outperforms other
techniques.
Discussion
This is a collaborative study of an interdisciplinary team,
composed of informaticians and a physician (a GP). The
role of a physician was in forming a research question
Figure 1 Sum of squared errors and k values with training set mode.
Table 6 Clusters obtained by k-means algorithm with
training set mode and k = 4
Attribute Cluster1 Cluster2 Cluster3 Cluster4
Age 14.5 14.0 16.0 16.0
Age of ARA 5.0 6.0 0.4 <1
Type of antibiotic cef&pen pen fenoksi ampicillin
Severity reaction skin skin skin skin
Age of the 1st antibiotic
use (y)
5.0 <1 <1 <1
Other allergic disease (skin) yes no no yes
Other allergic disease
(rhinitis)
no no no no
Other allergic disease
(bronchitis)
no no no yes
Other allergic disease
(asthma)
no no no no
Blood test on allergy - IgE positive positive positive positive
Perinatal disorders yes no no yes
Birth order 1 1.379 1.2828 1.2685
Severe respiratory disease yes no no Yes
Age of severe respiratoy
disease
1.5 6.0 6.0 6.0
Otitis media yes yes no Yes
Age of otitis media 9.0 <1 <1 <1
Other infections yes yes yes Yes
Other infections 1X 2X 2X 2X
Varicella yes no yes no
Age of varicella 7.5 3.0 3.0 3.0
Hospitalization <2y of age no no no no
Number of infections per
year
3-4X 2-3X 2-3X 3X
Antibiotic exposure before
ARA
2X 1X 1X 1X
Family history on ARA negative negative negative positive
Allergic diseases in family no no no no
Chr diseases in family no no no no
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and data collection and in providing comments on
health-related issues.
An overall frequency of ARA on antibiotics of 3,15%
was observed. Rarely available data for the paediatric
population indicate the overall incidence of 9,35% in
hospitalized children and 1,46% in outpatients [33].
Many factors can affect the variation in the frequency of
this disorder, including the children age (as shown in
our paper), the natural distribution of risk factors in the
population, the types of antibiotics prescribed, the cus-
tom of ARA recording and physicians’ education on
both, symptoms and mechanisms of ARA and antibiotic
prescription [34].
When all four clusters in parallel were put into con-
sideration, some general rules, in regard to ARA in chil-
dren, could be observed. As the first, there were two
time peaks of the ARA occurrence: in the year of birth
and in the late pre-school age (around 5-6 y). In older
children with ARA, the causing antibiotics were classi-
fied as with higher historical use (penicillin).
Some common characteristics of children with ARA
might include: 1) predisposition to allergic disorders
(positive IgE blood test), 2) however, not manifested with
allergic respiratory diseases (hay fever and asthma). This
connection should be taken into account even if it is
known that allergic diseases show the time-dependent
occurrence during the childhood (the so-called “allergic
march”, manifested as a progression of atopic diseases
from eczema to asthma), for reason that the current age
of cases with ARA corresponds with adolescence (14-16
year). These results seem contrary to what is known from
the early studies, that atopic subjects do not show higher
incidence of penicillin allergy, in comparison to the gen-
eral population [6]. It cannot, in fact, be known, from our
results, whether atopy in children can also increase their
predisposition for ARA on drugs (especially on antibio-
tics other than penicillin), or whether, on the contrary,
early antibiotic exposure increases the risk for atopic dis-
eases, as postulated traditionally [19]. Or, these results
may be only due to the confounding effects, consequently
to the predominant use of ß-lactam antibiotics in chil-
dren. Namely, undesirable reactions on these antibiotics
are known as being predominantly caused by allergic
mechanisms, usually mediated with IgE antibodies [6].
Nevertheless, these results can direct future prevention
strategies, mainly by means of preserved prescriptions of
antibiotics in children with increased IgE antibodies.
Other constant and common features of children with
ARA include: 3) at least one episode of infections (other
than respiratory infections, also including otitis media)
experienced before the time of ARA occurrence, as well
as an early antibiotic use (in the first year of life). These
results might be reflective of the immune system distur-
bation, in the early childhood, which can increase the
chance for both, ARA on antibiotics and infections.
Also, there are information that some infections can
serve as a promoting factor, by ensuring conditions for
the immune reaction on a drug to start, which otherwise
could not be the case [5]. In addition to these explana-
tions, the second result might also implicate the
increased risk for ARA to occur, through the negative
effect of an early antibiotic use on the commensal
intestinal flora and the subsequent impairments of the
immune system development [19], [20].
Some additional factors, found to commonly occur in
children with ARA, include: 4) frequent infections
(defined as two or more times per year), reflecting poor
hygiene, or the immune system dysfunction, and 5) low
antibiotic pre-exposure counts (1-2 times), indicating
sensitizing reaction as the possible mechanism of ARA.
In accordance to the latter, it is commonly known that
patients usually develop allergic reactions when reex-
posed to an antibiotic [6].
When clusters 3 and 4, representing an early onset of
ARA (during the first year of life), were compared to
each other, somewhat different patterns were obtained,
probably indicating different mechanisms between ARA
on ampicillin (a broad-spectrum antibiotic) and fenoksi-
metilpenicilin (a narrow-spectrum penicillin for an oral
use). Otherwise, these antibiotics share the common
structure, that of the ß-lactam antibiotic group, also
sharing some common features [5].
In regard to ampicillin, other allergic diseases, including
skin eczema and obstructive bronchitis (both disorders
occurring early along the course of the “allergic march”),
may contribute to the onset of ARA. These results are
likely to support the hypothesis, already presented above,
about the common pathogenetic background of both, ato-
pic diseases and ARA on antibiotics, in children. As an
alternative explanation of this connection, evidence has
been provided by many clinical studies, although not con-
sistently, that antibiotic exposure in early infancy is likely
to increase the risk for childhood atopy [19], [23]. This
inconsistency in knowledge gained on this issue, might be
the consequence of the different behavior of otherwise
similar substances, such as in our study the case with
fenoksimetil penicillin (cluster 3) and ampicillin (cluster
4). The unfavorable drug reaction, in ampicillin risk group
Table 7 Evaluation metrics for clustering algorithms
Algorithm Jaccard Index Fowlkes-Mallows Rand Index
K-means 0.5837 0.5350 0.5837
K-medoids 0.3750 0.6124 0.3750
K-medians 0.6033 0.7767 0.6033
Single link clustering 0.0227 0.1508 0.0227
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(cluster 4), according to our results, might also be sup-
ported with the existence of perinatal disorders, implicating
immunodeficiency and obstacles in the postnatal immune
system development. In numerous studies, conducted to-
date, an attention has not been paid to the importance of
these very early developmental disturbances. Furthermore,
our results also indicate that the occurrence of otitis media
in early life (in some reports considered as the complication
of influenza virus infection and, as such, the manifestation
of the immune system dysfunction) can also be considered
as a contributing factor for the early onset of ARA on
ampicillin (cluster 4). This risk group, in contrast to the
comparative one, for the time of onset (cluster 3), was also
prone to the development of severe respiratory disease,
although with the onset later in life (at six age), further
indicating immunodeficient disorders. When positive
family history on ARA is added to this risk group (cluster
4), this all together indicates that a set of inherited and
acquired immune system disorders can be important for
the occurrence of ARA on this broad-spectrum antibiotic.
Some elements of this pattern, associated with ARA on
ampicillin (cluster 4), can be recognized as a part of the
cluster describing ARA on cefalosporins (cef&pen, cluster
1), another broad-spectrum group of antibiotics. These
elements, overlapping between the two clusters, include
perinatal disorders and severe respiratory disease, although
here, the severe respiratory disease preceded (and probably
contributed to) the onset of ARA (cluster 1). The com-
bined cef&pen ARA event probably means allergic cross-
reaction that may occur between penicillin and cephalos-
porins of the older generation [6].
Also, it is interesting to observe that two very similar
antibiotics, from the common penicillin groups (clusters
2 and 3), have gained much of the similarity in their
risk factors patterns.
These results, indicating multiple factors clustered
within distinct patterns, each of them specifically asso-
ciated with a particular risk group (or an antibiotic), are
similar to the results of the studies on the association of
an early antibiotics use and the occurrence of allergic
diseases later in the childhood. According to these stu-
dies, a complex cause/outcome model should be formed,
in order to make conclusions on this issue, and it is not
possible to achieve by analyzing only one, or even a few
risk factors [19], [20], [24].
All these factors, extracted from the health records
and selected within four clusters, reflect patients’ (chil-
dren’s) clinical and pathophysiological features. We can
speculate that the reason why ARA on some other anti-
biotics, also listed above, have not been presented with a
cluster, might be the need for different clinical para-
meters selection, those ones not recorded in the health
records. Alternatively, some other factors could be
responsible for ARA, such as, for example, differences in
pharmacodynamic mechanisms of drug action. In con-
tribution to this latter explanation, very low ARA rates
for macrolide antibiotics have been reported [5].
Results of this study have confirmed some relatively
known facts about ARA in children, including the influ-
ence of early life infections and antibiotic prescriptions,
as well as the predomination of allergic mechanisms
underlying ARA, mostly mediated with IgE antibodies.
The nature of the association between atopy and ARA
in children, also important for understanding childhood
allergic diseases, remain to be elucidated in the future.
In fact, our results indicate that this association might
be important only for early ARA onset (in the first year
of life) and for a particular antibiotic used. The main
contribution of this paper is in the results clearly show-
ing for the first time that only a cluster of factors can
explain ARA, specifically for a particular children group,
or an antibiotic.
Results of this study can further be utilized for plan-
ning future research on this issue. They can also be use-
ful when preparing recommendations for antibiotics
prescription and to guide the standardized health data
record. Merely an increase in awareness of physicians
on risk factors for ARA in children can be sufficient to
change their attitudes towards antibiotics prescription.
Computer-based tools would be helpful in many aspects
when managing these issues, especially by means of the
possibility for systematic data recording and data model-
ing, suitable for the purpose of prediction and risk fac-
tors identification. Also important would be the drug
allergy alert and prescription support systems, as well as
programs for education promotion [41], [42].
We analyze health records created in a health center in
East Croatia to explore new knowledge for adverse reac-
tions and allergy (ARA) on antibiotics in children. The
broad application of business enterprise hospital informa-
tion systems utilizes large amounts of medical documents,
which need to be reviewed, observed, and analyzed by
human experts. There is need for some techniques which
provide the quality-based discovery, the extraction, the
integration and the use of hidden knowledge in those
documents [43]. Human-Computer Interaction and
Knowledge Discovery along with Biomedical Informatics
are of increasing importance to effectively gain knowledge,
to make sense out of the big data. In the future, we can
combine these fields to support the expert end users in
learning to interactively analyze information properties
thus enabling them to visualize the adverse reactions and
allergy (ARA) on antibiotics data [44].
Conclusions
Biomedical research aims to search new and meaningful
knowledge to provide better healthcare [45-47]. Adverse
reactions and allergy (ARA) from antibiotics in children
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is an important research issue for the medical domain. In
this study, we targeted on knowledge discovery for this
problem and perform a study based on data mining to
predict clusters in the survey data extracted from health
records of children in Eastern Croatia.
We used computational techniques and then applied
k-means algorithm to the dataset to generate some clus-
ters which have similar features. Our results highlight that
some type of antibiotics form different clusters. Medical
researchers and pharmaceutical companies can utilize and
interpret our results. Despite that our study has some lim-
itations, for example we have small dataset consisting of
42 instances, we hope that we can extend the dataset and
apply data mining algorithms on it in the future.
In conclusion, we believe that our study can be good
example on data mining for adverse reactions and
allergy (ARA) from antibiotics in children.
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